Rohan Arambepola

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Mass Spectrometry

Top Venues

PLOS global public health

Statistics in medicine

medRxiv : the preprint server for health sciences

Addiction (Abingdon, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Stacie Loisate, Simon Mutembo, Rohan Arambepola, Kabondo Makungo, Elliot N Kabalo, Nyambe B Sinyange, Nathan Kapata, Mazyanga Liwewe, Andrew Silumezi, Gershom Chongwe, Natalya Kostandova, Shaun Truelove, Amy Wesolowski
Changes in mobility patterns during the COVID-19 pandemic in Zambia: Implications for the effectiveness of NPIs in Sub-Saharan Africa. PLOS global public health 3 (10) (2023)
Rohan Arambepola, Kathryn L Schaber, Catherine Schluth, Angkana T Huang, Alain B Labrique, Shruti H Mehta, Sunil S Solomon, Derek A T Cummings, Amy Wesolowski
Fine scale human mobility changes within 26 US cities in 2020 in response to the COVID-19 pandemic were associated with distance and income. PLOS global public health 3 (7) (2023)
Rohan Arambepola, Kathryn L Schaber, Catherine Schluth, Angkana T Huang, Alain B Labrique, Shruti H Mehta, Sunil S Solomon, Derek A T Cummings, Amy Wesolowski
Fine scale human mobility changes in 26 US cities in 2020 in response to the COVID-19 pandemic were associated with distance and income. medRxiv : the preprint server for health sciences (2022)
Rohan Arambepola, Tim C D Lucas, Anita K Nandi, Peter W Gething, Ewan Cameron
A simulation study of disaggregation regression for spatial disease mapping. Statistics in medicine (2021)
Natalie Gold, Mark Egan, Kristina Londakova, Abigail L Mottershaw, Hugo Harper, Robyn Burton, Clive Henn, Maria Smolar, Matthew Walmsley, Rohan Arambepola, Robin Watson, Sarah Bowen, Felix Greaves
Effect of alcohol label designs with different pictorial representations of alcohol content and health warnings on knowledge and understanding of low-risk drinking guidelines: a randomized controlled trial. Addiction (Abingdon, England) 116 (6) (2021)